Bupropion (Wellbutrin) Can Worsen Anxiety, But the Risk Is Lower Than Commonly Believed
Your concern about bupropion worsening anxiety is valid but likely overstated—recent evidence suggests bupropion has comparable anxiolytic effects to SSRIs like sertraline in patients with depression and comorbid anxiety, though it requires careful initiation and monitoring.
Understanding the Evidence
The clinical belief that bupropion exacerbates anxiety has been challenged by recent research. A large naturalistic study of 8,457 patients found no difference in anxiety outcomes between those prescribed SSRIs versus bupropion over 12 weeks of treatment 1. Similarly, pooled data from 10 randomized trials involving 2,890 patients showed that bupropion and SSRIs produced comparable reductions in anxiety symptoms when treating major depressive disorder 2.
However, bupropion's stimulating properties can provoke anxiety, particularly at higher doses or with rapid initiation 3. This is why the approach to starting bupropion matters significantly.
Practical Approach to Switching from Sertraline to Bupropion
Discontinuation of Sertraline
First, address the sertraline discontinuation properly. Sertraline is associated with discontinuation syndrome characterized by dizziness, anxiety, irritability, sensory disturbances, and mood changes 4. Taper sertraline gradually rather than stopping abruptly—reduce the dose incrementally over at least 1-2 weeks, or longer if you've been on it for extended periods 5. Monitor for withdrawal symptoms during this period, as these can mimic or worsen anxiety.
Initiating Bupropion
Start bupropion at a low dose (150 mg once daily) and increase slowly 6. The standard approach is:
- Days 1-3: 150 mg once daily in the morning
- After Day 4: If tolerated, increase to 150 mg twice daily (maximum 300 mg/day)
Take the second dose before 3 PM to minimize insomnia risk 6, which can secondarily worsen anxiety.
Key Monitoring Points
Watch for these specific anxiogenic warning signs in the first 2-4 weeks:
- Increased restlessness or agitation (common early side effect)
- Insomnia (occurs in 16-25% of patients) 5
- Tremor (occurs in 8-11% of patients) 5
If anxiety worsens significantly, this typically manifests within the first few weeks 3. The time to clinically significant anxiolytic effect, when it occurs, is approximately 4 weeks—comparable to SSRIs 7, 8.
Who Should Avoid Bupropion
Absolute contraindications relevant to anxiety:
- Active seizure disorder or history of seizures 9, 10
- Current severe anxiety or panic disorder (relative contraindication)
- Concurrent use of MAOIs 10
Evidence-Based Reassurance
Multiple studies demonstrate that baseline anxiety levels do not predict poor response to bupropion 8. In fact, bupropion-treated patients with depression and comorbid anxiety showed marked reductions in Hamilton Anxiety Scale scores comparable to sertraline-treated patients 7. The median time to achieve ≥50% reduction in anxiety symptoms was identical (4 weeks) for both medications 7.
Alternative Consideration
If you have significant anxiety that dominates your clinical picture (rather than depression with anxiety features), consider switching to a different SSRI (such as escitalopram or citalopram, which have fewer drug interactions 4) rather than bupropion. For depression with mild-to-moderate anxiety, bupropion remains a reasonable option 3, 2.
Bottom Line Algorithm
- Taper sertraline gradually over 1-2+ weeks
- Start bupropion 150 mg once daily in the morning
- Monitor closely for 2-4 weeks for increased anxiety, insomnia, or agitation
- If tolerated, increase to 150 mg twice daily after 3-7 days
- Reassess at 4 weeks—if anxiety worsens persistently or depression doesn't improve, consider switching to another SSRI rather than continuing bupropion
The key is starting low, going slow, and maintaining close monitoring during the transition period.